Literature DB >> 22147000

Incidence, predictive factors, and prognosis of chondrosarcoma in patients with Ollier disease and Maffucci syndrome: an international multicenter study of 161 patients.

Suzan H M Verdegaal1, Judith V M G Bovée, Twinkal C Pansuriya, Robert J Grimer, Harzem Ozger, Paul C Jutte, Mikel San Julian, David J Biau, Ingrid C M van der Geest, Andreas Leithner, Arne Streitbürger, Frank M Klenke, Francois G Gouin, Domenico A Campanacci, Perrine Marec-Berard, Pancras C W Hogendoorn, Ronald Brand, Antonie H M Taminiau.   

Abstract

BACKGROUND: Enchondromatosis is characterized by the presence of multiple benign cartilage lesions in bone. While Ollier disease is typified by multiple enchondromas, in Maffucci syndrome these are associated with hemangiomas. Studies evaluating the predictive value of clinical symptoms for development of secondary chondrosarcoma and prognosis are lacking. This multi-institute study evaluates the clinical characteristics of patients, to get better insight on behavior and prognosis of these diseases.
METHOD: A retrospective study was conducted using clinical data of 144 Ollier and 17 Maffucci patients from 13 European centers and one national databank supplied by members of the European Musculoskeletal Oncology Society.
RESULTS: Patients had multiple enchondromas in the hands and feet only (group I, 18%), in long bones including scapula and pelvis only (group II, 39%), and in both small and long/flat bones (group III, 43%), respectively. The overall incidence of chondrosarcoma thus far is 40%. In group I, only 4 patients (15%) developed chondrosarcoma, in contrast to 27 patients (43%) in group II and 26 patients (46%) in group III, respectively. The risk of developing chondrosarcoma is increased when enchondromas are located in the pelvis (odds ratio, 3.8; p = 0.00l).
CONCLUSIONS: Overall incidence of development of chondrosarcoma is 40%, but may, due to age-dependency, increase when considered as a lifelong risk. Patients with enchondromas located in long bones or axial skeleton, especially the pelvis, have a seriously increased risk of developing chondrosarcoma, and are identified as the population that needs regular screening on early detection of malignant transformation.

Entities:  

Mesh:

Year:  2011        PMID: 22147000      PMCID: PMC3248776          DOI: 10.1634/theoncologist.2011-0200

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  32 in total

Review 1.  [Chondrosarcoma secondary to multiple cartilage diseases. Study of 29 clinical cases and review of the literature].

Authors:  F Schaison; P Anract; F Coste; G De Pinieux; M Forest; B Tomeno
Journal:  Rev Chir Orthop Reparatrice Appar Mot       Date:  1999-12

2.  Usefulness of radiography in differentiating enchondroma from central grade 1 chondrosarcoma.

Authors:  M J Geirnaerdt; J Hermans; J L Bloem; H M Kroon; T L Pope; A H Taminiau; P C Hogendoorn
Journal:  AJR Am J Roentgenol       Date:  1997-10       Impact factor: 3.959

3.  Chondrosarcoma of the phalanx: a locally aggressive lesion with minimal metastatic potential: a report of 35 cases and a review of the literature.

Authors:  J V Bovée; R O van der Heul; A H Taminiau; P C Hogendoorn
Journal:  Cancer       Date:  1999-11-01       Impact factor: 6.860

4.  The management of leg-length discrepancy in Ollier's disease with a fully implantable lengthening nail.

Authors:  R Baumgart; D Bürklein; S Hinterwimmer; P Thaller; W Mutschler
Journal:  J Bone Joint Surg Br       Date:  2005-07

5.  Enchondromatosis (Ollier disease, Maffucci syndrome) is not caused by the PTHR1 mutation p.R150C.

Authors:  Leida B Rozeman; Luca Sangiorgi; Inge H Briaire-de Bruijn; Pierre Mainil-Varlet; F Bertoni; Anne Marie Cleton-Jansen; Pancras C W Hogendoorn; Judith V M G Bovée
Journal:  Hum Mutat       Date:  2004-12       Impact factor: 4.878

Review 6.  Enchondromatosis: insights on the different subtypes.

Authors:  Twinkal C Pansuriya; Herman M Kroon; Judith V M G Bovée
Journal:  Int J Clin Exp Pathol       Date:  2010-06-26

7.  Magnetic resonance imaging of cartilaginous tumors: is it useful or necessary?

Authors:  L H De Beuckeleer; A M De Schepper; F Ramon
Journal:  Skeletal Radiol       Date:  1996-02       Impact factor: 2.199

8.  Bone sarcomas associated with Ollier's disease.

Authors:  J Liu; P G Hudkins; R G Swee; K K Unni
Journal:  Cancer       Date:  1987-04-01       Impact factor: 6.860

9.  Cartilaginous tumors: correlation of gadolinium-enhanced MR imaging and histopathologic findings.

Authors:  M J Geirnaerdt; J L Bloem; F Eulderink; P C Hogendoorn; A H Taminiau
Journal:  Radiology       Date:  1993-03       Impact factor: 11.105

10.  IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours.

Authors:  M Fernanda Amary; Krisztian Bacsi; Francesca Maggiani; Stephen Damato; Dina Halai; Fitim Berisha; Robin Pollock; Paul O'Donnell; Anita Grigoriadis; Tim Diss; Malihe Eskandarpour; Nadège Presneau; Pancras Cw Hogendoorn; Andrew Futreal; Roberto Tirabosco; Adrienne M Flanagan
Journal:  J Pathol       Date:  2011-05-19       Impact factor: 9.883

View more
  46 in total

1.  Somatic IDH1 mutation in a pituitary adenoma of a patient with Maffucci syndrome.

Authors:  Shuyu Hao; Christopher S Hong; Jie Feng; Chunzhang Yang; Prashant Chittiboina; Junting Zhang; Zhengping Zhuang
Journal:  J Neurosurg       Date:  2015-10-16       Impact factor: 5.115

2.  [Chondrosarcoma of the hand arising from multiple enchondromas: a case report].

Authors:  R B Wirth-Welle; Q Simon; M A Bonaccio
Journal:  Orthopade       Date:  2020-01       Impact factor: 1.087

Review 3.  Genetic alterations in chondrosarcomas - keys to targeted therapies?

Authors:  Andre M Samuel; Jose Costa; Dieter M Lindskog
Journal:  Cell Oncol (Dordr)       Date:  2014-01-24       Impact factor: 6.730

Review 4.  [Challenges in the diagnosis of cartilage tumors : Morphological spectrum and molecular markers].

Authors:  Wolfgang Hartmann
Journal:  Orthopade       Date:  2019-09       Impact factor: 1.087

Review 5.  Understanding venous malformations of the head and neck: a comprehensive insight.

Authors:  Giacomo Colletti; Anna Maria Ierardi
Journal:  Med Oncol       Date:  2017-02-08       Impact factor: 3.064

6.  [Benign cartilage tumors. What should I do with incidental findings?].

Authors:  M Nottrott; J Hardes; G Gosheger; D Andreou; M Henrichs; A Streitbuerger
Journal:  Unfallchirurg       Date:  2014-10       Impact factor: 1.000

7.  Mutant IDH is sufficient to initiate enchondromatosis in mice.

Authors:  Makoto Hirata; Masato Sasaki; Rob A Cairns; Satoshi Inoue; Vijitha Puviindran; Wanda Y Li; Bryan E Snow; Lisa D Jones; Qingxia Wei; Shingo Sato; Yuning J Tang; Puviindran Nadesan; Jason Rockel; Heather Whetstone; Raymond Poon; Angela Weng; Stefan Gross; Kimberly Straley; Camelia Gliser; Yingxia Xu; Jay Wunder; Tak W Mak; Benjamin A Alman
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-17       Impact factor: 11.205

8.  Maffucci Syndrome with Clival Enchondroma in Nasopharynx: A Case Report.

Authors:  Swathi Velagapudi; Saad M Alshammari; Suresh Velagapudi
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-08-10

Review 9.  The role of metabolic enzymes in mesenchymal tumors and tumor syndromes: genetics, pathology, and molecular mechanisms.

Authors:  Inga-Marie Schaefer; Jason L Hornick; Judith V M G Bovée
Journal:  Lab Invest       Date:  2018-01-16       Impact factor: 5.662

10.  Phase I Study of the Mutant IDH1 Inhibitor Ivosidenib: Safety and Clinical Activity in Patients With Advanced Chondrosarcoma.

Authors:  William D Tap; Victor M Villalobos; Gregory M Cote; Howard Burris; Filip Janku; Olivier Mir; Murali Beeram; Andrew J Wagner; Liewen Jiang; Bin Wu; Sung Choe; Katharine Yen; Camelia Gliser; Bin Fan; Sam Agresta; Shuchi S Pandya; Jonathan C Trent
Journal:  J Clin Oncol       Date:  2020-03-24       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.